Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age7-17
SponsorWashington University School of Medicine

About this trial

The overall goal of this study is to attempt to overcome the organizational barriers that impede prompt screening for at-risk sensory deficits in childhood cancer survivors (CCS). Using a cross sectional design study, collaborators in the Informatics Research branch of the Institute of Informatics at the Washington University School of Medicine will identify CCS at risk for sensory deficits based upon their therapy exposure to generate the highlighting patients at risk for sensory screening (HPARSS) document. The investigators will utilize the HPARSS that will link therapy related risks for sensory deficits to specific screening procedures prompting the primary oncology provider to implement screening, diagnostic testing, and therapy.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients with a diagnosis of pediatric cancer (diagnosis at <18 years of age)

Treatment including chemotherapy and/or radiation therapy

Completion of all cancer therapy for at least 6 months and less than 2 years

Followed in the Division of Pediatric Hematology/Oncology Program at the Washington University School of Medicine

Disqualifiers

Undergoing active cancer treatment

Patient under the care of the Late Effects Program at St. Louis Children's Hospital

Received previous diagnostic testing or rehabilitative therapy for a secondary deficit eligible for screening.

Parents and/or patient illiteracy

Trial design

Design model

Parallel

Treatments tested in this trial

  • Highlighting Patients at Risk for Sensory Screening (HPARSS)

    Other intervention

    Collaborators in the Informatics Research branch of the Institute of Informatics at the Washington University School of Medicine will identify CCS at risk for sensory deficits based upon their therapy exposure to generate the HPARSS document.

Treatment groups

146 Participants
are divided into 2 treatment groups
Group A: Patients: Highlighting Patients at Risk for Sensory Screening (HPARSS)Experimental treatment 1 intervention
Group B: Providers: Highlighting Patients at Risk for Sensory Screening (HPARSS)No intervention 0 interventions

Trial outcomes

Primary outcomes

1

Percentage of patients with at risk for sensory deficits identified by HPARSS

Time frame
Through completion of enrollment for all patients (estimated to be 9 months)
2

Percentage of at risk patients who fail the assigned screening test

Time frame
Through completion of enrollment for all patients (estimated to be 9 months)
3

Percentage of patients in need of referral for screen test results who participate in formal diagnostic testing and/or treatment

Time frame
Through 1 year after the completion of screening test for all participants (estimated to be 1 year and 9 months)

Secondary outcomes

1

Number and types of barriers to participation in formal diagnostic testing and therapy in CCS failing to engage in sensory screening

Time frame
At approximately 2 months following the patient's screening
2

Number and types of facilitators to participation in formal diagnostic testing and therapy in CCS failing to engage in sensory screening

Time frame
At approximately 2 months following the patient's screening
3

Acceptability of HPARSS as measured by the Acceptability of Intervention Measure (AIM)

-4 questions inquiring about the acceptability of HPARSS with answers ranging from completely disagree=1 to completely agree=5. The higher the score indicates higher acceptability of the HPARSS.

Time frame
To be completed at the time of enrollment completion (approximately 9 months)
4

Feasibility of intervention as measured by Feasibility of Intervention Measure (FIM)

-4 questions inquiring about the feasibility of HPARSS with answers ranging from completely disagree=1 to completely agree=5. The higher the score indicates higher feasibility of the HPARSS.

Time frame
To be completed at the time of enrollment completion (approximately 9 months)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Washington University School of Medicine

Lead sponsor

St. Jude Children's Research Hospital

Collaborator